Rowland Charles A Jr
SEC CIK 1383292 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | Dir | 33.1K | — | $3.13M | 5 | 2023-05-16 | 2026-01-02 |
Most active insiders at VKTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lian Brian | Pres, CEO, Dir | — | $14.01M |
| 2 | ZANTE GREG | CFO | — | $2.82M |
| 3 | Mancini Marianna | COO | — | $2.73M |
| 4 | Rowland Charles A Jr | Dir | — | $2.13M |
| 5 | FOEHR MATTHEW W | Dir | — | $561.8K |
| 6 | Aubuchon Neil William | Chief Commercial Off | $149.9K | — |
| 7 | Kelly-Gemmell Dorothy Elizabeth | Dir | — | — |
| 8 | Rouan Sarah Kathryn | Dir | — | — |
| 9 | MACARTNEY LAWSON | Dir | — | — |
| 10 | SINGLETON J MATTHEW | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-02 | VKTX | Viking Therapeutics, Inc. | Rowland Charles A Jr | Dir | A - Grant | $0.00 | +3,150 | 33.1K | +10% | $0 |
| D | 2025-10-28 | 2025-10-27 | VKTX | Viking Therapeutics, Inc. | Rowland Charles A Jr | Dir | S - Sale | $35.57 | -60.0K | 30.0K | -67% | -$2.13M |
| DM | 2025-10-28 | 2025-10-27 | VKTX | Viking Therapeutics, Inc. | Rowland Charles A Jr | Dir | A - Grant | $5.11 | +60.0K | 46.0K | New | +$306.6K |
| D | 2023-05-18 | 2023-05-16 | VKTX | Viking Therapeutics, Inc. | Rowland Charles A Jr | Dir | M - OptEx | $1.08 | +40.0K | 70.0K | +133% | +$43.2K |
| D | 2023-05-18 | 2023-05-16 | VKTX | Viking Therapeutics, Inc. | Rowland Charles A Jr | Dir | S - Sale+OE | $25.00 | -40.0K | 30.0K | -57% | -$1.00M |
Purchase Sale Sale after option exercise All abbreviations